Trading of Spago Nanomedical shares on Nasdaq First North Growth market starts today
“Facilitation of healthcare and saving lives should always be a good investment. At Spago Nanomedical we are committed to improving treatment and diagnostics of life-threatening diseases as we continue to build our business. The listing at Nasdaq First North Gorwth Market is a stepping stone for continued value creation for our owners and eventually for patients with cancer. It marks the beginning of the next chapter of Spago Nanomedical”, says CEO Mats Hansen.